Traws Pharma Inc. – Transcripts

NASDAQ: TRAW
Share price (5/21/26): $1.49
Market cap (5/21/26): $22.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Transcripts

All mentions

CY 2026

Earnings Revised 04/16/26 Traws Pharma, Inc., 2025 Earnings Call, Apr 15, 2026 04/15/26

CY 2025

Earnings Revised 08/14/25 Traws Pharma, Inc., Q2 2025 Earnings Call, Aug 14, 2025 08/14/25

Other Revised 03/31/25 Traws Pharma, Inc. - Special Call 03/31/25

CY 2024

Earnings Revised 09/02/24 Traws Pharma, Inc., Q2 2024 Earnings Call, Aug 15, 2024 08/15/24

M&A Revised 04/02/24 Onconova Therapeutics, Inc. - M&A Call 04/02/24

CY 2023

Earnings Revised 01/05/24 Onconova Therapeutics, Inc., Q3 2023 Earnings Call, Nov 14, 2023 11/14/23

Earnings Revised 08/18/23 Onconova Therapeutics, Inc., Q2 2023 Earnings Call, Aug 10, 2023 08/10/23

Earnings Revised 05/29/23 Onconova Therapeutics, Inc., Q1 2023 Earnings Call, May 15, 2023 05/15/23

Earnings Revised 03/16/23 Onconova Therapeutics, Inc., Q4 2022 Earnings Call, Mar 16, 2023 03/16/23

CY 2022

Earnings Revised 11/14/22 Onconova Therapeutics, Inc., Q3 2022 Earnings Call, Nov 14, 2022 11/14/22

Earnings Revised 08/11/22 Onconova Therapeutics, Inc., Q2 2022 Earnings Call, Aug 11, 2022 08/11/22

Earnings Revised 05/11/22 Onconova Therapeutics, Inc., Q1 2022 Earnings Call, May 11, 2022 05/11/22

Earnings Revised 03/17/22 Onconova Therapeutics, Inc., Q4 2021 Earnings Call, Mar 17, 2022 03/17/22

CY 2021

Earnings Revised 11/11/21 Onconova Therapeutics, Inc., Q3 2021 Earnings Call, Nov 11, 2021 11/11/21

Other Revised 09/22/21 Onconova Therapeutics, Inc. - Special Call 09/22/21

Earnings Revised 02/20/24 Onconova Therapeutics, Inc., Q2 2021 Earnings Call, Aug 12, 2021 08/12/21

Earnings Revised 05/17/21 Onconova Therapeutics, Inc., Q1 2021 Earnings Call, May 17, 2021 05/17/21

Other Revised 04/30/21 Onconova Therapeutics, Inc. - Shareholder/Analyst Call 04/30/21

Other Revised 04/01/21 Onconova Therapeutics, Inc. - Shareholder/Analyst Call 04/01/21

Earnings Revised 03/11/21 Onconova Therapeutics, Inc., 2020 Earnings Call, Mar 11, 2021 03/11/21

Other Revised 03/04/21 Onconova Therapeutics, Inc. - Shareholder/Analyst Call 03/04/21

CY 2020

Earnings Revised 11/12/20 Onconova Therapeutics, Inc., Q3 2020 Earnings Call, Nov 12, 2020 11/12/20

Other Revised 08/24/20 Onconova Therapeutics, Inc. - Special Call 08/24/20

Earnings Revised 08/12/20 Onconova Therapeutics, Inc., Q2 2020 Earnings Call, Aug 12, 2020 08/12/20

Other Revised 06/26/20 Onconova Therapeutics, Inc. - Shareholder/Analyst Call 06/26/20

Other Revised 05/27/20 Onconova Therapeutics, Inc. - Shareholder/Analyst Call 05/27/20

Earnings Revised 05/14/20 Onconova Therapeutics, Inc., Q1 2020 Earnings Call, May 14, 2020 05/14/20

Earnings Revised 03/24/20 Onconova Therapeutics, Inc., 2019 Earnings Call, Mar 24, 2020 03/24/20

CY 2019

Earnings Revised 08/14/19 Onconova Therapeutics, Inc., Q2 2019 Earnings Call, Aug 14, 2019 08/14/19

Earnings Revised 05/14/19 Onconova Therapeutics, Inc., Q1 2019 Earnings Call, May 14, 2019 05/14/19

Earnings Revised 03/26/19 Onconova Therapeutics, Inc., 2018 Earnings Call, Mar 26, 2019 03/26/19

Other Revised 02/07/19 Onconova Therapeutics, Inc. - Shareholder/Analyst Call 02/07/19

CY 2018

Earnings Revised 11/13/18 Onconova Therapeutics, Inc., Q3 2018 Earnings Call, Nov 13, 2018 11/13/18